Valuation models
price $432.01 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused136.25 – 174.92152.93182% overvaluedDCF · Perpetuity growth · 10y160.17 – 208.74181.10139% overvaluedDCF · EBITDA exit · 5y209.52 – 226.19217.6399% overvaluedDCF · EBITDA exit · 10y223.16 – 256.99239.2881% overvaluedP/E · peers201.71 – 210.33204.40111% overvaluedP/E · own history557.42 – 821.62716.1840% undervaluedPEG—202.08114% overvaluedEV/EBITDA · peers129.78 – 186.44136.65216% overvaluedEV/Revenue · peers60.45 – 80.5661.55602% overvaluedEarnings power value69.26 – 87.4677.04461% overvaluedWall St. consensus target—500.0014% belowCost of capital (WACC)—10.35%—
DCF · Perpetuity growth · 5y leads for a high-growth company — positive operating income and three years of positive free cash flow. How the headline model is chosen. The price is 182% above the model value: the models see only the filed business, and a company priced on businesses with no revenue line yet is better taken apart, as Tesla is.
Model value · DCF · Perpetuity growth · 5y
152.93
Intuitive Surgical closed at $432.01 — overvalued by 182% vs model.
136.25the model's range174.92
DCF · Perpetuity growth · 5y leads for a high-growth company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
61.55 – 716.18
Wall St. target
500.00 14% below
Above model, 1y
31 of 31 days
How it is valued
Valued asHigh growth
Moderate growth (~19% recent)High profitability (28% net margin)Moderately volatile earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.